Artemis Medicare Services Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

Technical Trend Overview and Price Movement

As of 12 Feb 2026, Artemis Medicare’s stock price closed at ₹234.20, slightly down by 0.36% from the previous close of ₹235.05. The intraday range was relatively narrow, with a low of ₹231.90 and a high of ₹238.30. The stock remains well below its 52-week high of ₹305.95 but comfortably above its 52-week low of ₹208.75, indicating a consolidation phase after a period of volatility.

The technical trend has shifted from mildly bullish to sideways, signalling a pause in upward momentum. This is reflected in the daily moving averages, which remain mildly bullish, suggesting some underlying support. However, weekly and monthly indicators paint a more cautious picture.

MACD and Momentum Oscillators

The Moving Average Convergence Divergence (MACD) indicator, a key momentum gauge, shows bearish signals on the weekly chart and mildly bearish on the monthly chart. This suggests that the medium-term momentum is weakening, with the MACD line likely below the signal line, indicating potential selling pressure. Conversely, the Relative Strength Index (RSI) remains bullish on both weekly and monthly timeframes, signalling that the stock is not yet oversold and retains some buying interest.

This divergence between MACD and RSI highlights a nuanced momentum scenario: while trend-following indicators suggest caution, momentum oscillators indicate resilience. Traders should be wary of this mixed message, as it often precedes a period of consolidation or a potential reversal.

Bollinger Bands and Volatility

Bollinger Bands, which measure price volatility and potential overbought or oversold conditions, are mildly bearish on the weekly chart and bearish on the monthly chart. The stock price is likely trading near the lower band on the monthly scale, indicating increased volatility and a possible downward pressure. This aligns with the sideways trend and suggests that Artemis Medicare may be experiencing a phase of price compression before a decisive move.

Moving Averages and KST Indicator

Daily moving averages remain mildly bullish, indicating that short-term price momentum is holding some ground. This is a positive sign for traders looking for entry points on dips. However, the Know Sure Thing (KST) indicator, which aggregates multiple rate-of-change calculations, is mildly bearish on both weekly and monthly charts. This suggests that the broader momentum is weakening, and the stock may struggle to sustain upward moves without stronger buying interest.

Volume and Dow Theory Signals

On-Balance Volume (OBV) shows no clear trend on the weekly chart and is mildly bearish on the monthly chart. This indicates that volume is not strongly supporting price advances, a warning sign for sustained rallies. Dow Theory analysis concurs, showing no trend on the weekly timeframe and mildly bearish conditions monthly. Together, these volume and trend confirmations suggest that the stock is in a consolidation phase with a slight bearish bias.

Comparative Returns and Market Context

Examining Artemis Medicare’s returns relative to the Sensex provides further insight. Over the past week, the stock outperformed the Sensex with a 9.24% gain versus the index’s 0.50%. However, this short-term strength is offset by weaker longer-term performance. The stock has declined 9.31% over the past month and 13.58% year-to-date, compared to the Sensex’s modest gains of 0.79% and a 1.16% decline respectively. Over one year, Artemis Medicare’s return is -11.44%, while the Sensex gained 10.41%. Despite this, the company’s three- and five-year returns remain impressive at 239.42% and 998.24%, far outpacing the Sensex’s 38.81% and 63.46% respectively, underscoring its strong long-term growth trajectory.

Mojo Score and Grade Upgrade

MarketsMOJO’s proprietary scoring system has upgraded Artemis Medicare’s Mojo Grade from Sell to Hold as of 09 Feb 2026, reflecting an improvement in technical and fundamental parameters. The current Mojo Score stands at 64.0, indicating a moderate investment appeal. The Market Cap Grade is 3, suggesting a mid-sized market capitalisation relative to peers. This upgrade signals cautious optimism but advises investors to monitor momentum indicators closely before committing fresh capital.

Investor Implications and Outlook

Investors should approach Artemis Medicare with a balanced perspective. The recent technical upgrade to Hold reflects stabilising fundamentals and some short-term bullish signals, particularly from the RSI and daily moving averages. However, the bearish MACD, Bollinger Bands, KST, and volume indicators caution against expecting a strong breakout in the near term.

Given the sideways trend and mixed momentum signals, the stock appears to be in a consolidation phase. This may offer tactical trading opportunities for investors with a medium-term horizon, especially if the price holds above key support levels near ₹230. However, a sustained move above the 50-day and 200-day moving averages would be necessary to confirm a return to a bullish trend.

Long-term investors can take comfort from Artemis Medicare’s robust multi-year returns and improving Mojo Grade, but should remain vigilant for signs of trend reversal or further technical deterioration. Monitoring the interplay between MACD and RSI, alongside volume trends, will be critical in assessing the stock’s next directional move.

Conclusion

Artemis Medicare Services Ltd is currently navigating a complex technical landscape characterised by a shift from mild bullishness to sideways momentum. While short-term indicators like RSI and daily moving averages offer some optimism, the broader weekly and monthly signals suggest caution. The stock’s recent Mojo Grade upgrade to Hold reflects this nuanced outlook, balancing solid fundamentals against technical headwinds. Investors should weigh these factors carefully, considering both the company’s impressive long-term returns and the current consolidation phase before making investment decisions.

Unlock special upgrade rates for a limited period. Start Saving Now →